FIELD: medicine.
SUBSTANCE: method involves taking marrow suspension into two flasks with Glucigir in the amount of 100,0 ml in each of them before operation at the first treatment day. Cysplatin is added into one of the flasks on the basis of 100 mg/m2, and 1000 mg of 5-fluorouracyl is added to the second flask. The mixture is incubated and intravenously drop-by-drop introduced. Exfusion of 100 ml of marrow suspension into flask containing Glucigir is repeated at the eighth treatment day. It is combined with 1000 mg of 5-fluorouracyl, incubated and intravenously drop-by-drop introduced.
EFFECT: improved patient health condition; increased organism resistance level; prolonged period of no relapse.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATMENT OF RELAPSES IN ONCOGYNECOLOGICAL PATIENTS | 2005 |
|
RU2296564C2 |
METHOD OF TREATING RECURRENT NASOPHARYNX CANCER | 2009 |
|
RU2420333C2 |
BREAST CANCER TREATMENT METHOD | 2001 |
|
RU2195295C1 |
METHOD FOR TREATMENT OF MOUTH CAVITY ORGANS AND PHARYNX LOCALLY SPREAD CANCER | 2002 |
|
RU2231355C2 |
WAY OF TREATMENT OF REFRACTORY FORMS OF LYMPHOGRANULOMATOSIS | 2008 |
|
RU2359683C1 |
METHOD OF TREATMENT BREAST CANCER | 2008 |
|
RU2393888C1 |
METHOD FOR TREATING LOCAL LARYNGEAL CANCER | 2002 |
|
RU2211042C1 |
METHOD FOR CONSERVATIVE TREATMENT IN PATIENTS AT NONOPERABLE PULMONARY CARCINOMA | 2005 |
|
RU2311185C2 |
METHOD FOR TREATING GENERALIZED SKIN MELANOMA | 2005 |
|
RU2301061C2 |
METHOD FOR TREATING MALIGNANT TUMORS | 2001 |
|
RU2210390C2 |
Authors
Dates
2006-03-20—Published
2004-08-18—Filed